Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Petros G. Nikolinakos"'
Autor:
Young Min Cho, Erik W. Anderson, Sara Guevara, Santiago J. Miyara, Aqsa Iqbal, Judith Aronsohn, Ernesto P. Molmenti, James M. Mumford, Barbara Keber, Farideh Zonouzi-Zadeh, Yousoun Ha, Petros G. Nikolinakos, Brent Flickinger
Publikováno v:
Journal of Clinical Rheumatology and Immunology, Vol 22, Iss 01, Pp 22-30 (2022)
T-cell large granular lymphocyte (T-LGL) leukemia is a rare and indolent clonal disorder of LGLs, associated with rheumatoid arthritis and neutropenia. The authors present a case of a 62-year-old male with rheumatoid arthritis (RA) who was diagnosed
Externí odkaz:
https://doaj.org/article/7a764eca4f9a48dbbd511e76ba0c7355
Autor:
Patrick B. Johnston, Amanda F. Cashen, Petros G. Nikolinakos, Anne W. Beaven, Stefan Klaus Barta, Gajanan Bhat, Steven J. Hasal, Sven De Vos, Yasuhiro Oki, Changchun Deng, Francine M. Foss
Publikováno v:
Experimental Hematology & Oncology, Vol 10, Iss 1, Pp 1-11 (2021)
Abstract Background Belinostat is a histone deacetylase inhibitor approved for relapsed refractory peripheral T-cell lymphoma (PTCL). The primary objective of this study was to determine the maximum tolerated dose (MTD) of belinostat combined with CH
Externí odkaz:
https://doaj.org/article/af527152ded04cb9a0629860f5f6b4cf
Autor:
Nizar M. Tannir, Keith Orford, Lalith Akella, Hema Parmar, Zhentao Zhang, Yousef Zakharia, Arash Rezazadeh Kalebasty, Petros G. Nikolinakos, Oscar B. Goodman, Benjamin A. Gartrell, Alice C. Fan, Johanna Bendell, Montaser Shaheen, Vijay Patel, Steven McCune, Sandy Liu, Ulka Vaishampayan, Arif Hussain, James J. Hsieh, Ivor Percent, Marc Matrana, Hamid Emamekhoo, Robert Motzer, Chung-Han Lee
Purpose:Glutaminase is a key enzyme, which supports elevated dependency of tumors on glutamine-dependent biosynthesis of metabolic intermediates. Dual targeting of glucose and glutamine metabolism by the mTOR inhibitor everolimus plus the oral glutam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a186504f410b1b44c1a1931aa5a0590
https://doi.org/10.1158/1078-0432.c.6532388
https://doi.org/10.1158/1078-0432.c.6532388
Autor:
Nizar M. Tannir, Keith Orford, Lalith Akella, Hema Parmar, Zhentao Zhang, Yousef Zakharia, Arash Rezazadeh Kalebasty, Petros G. Nikolinakos, Oscar B. Goodman, Benjamin A. Gartrell, Alice C. Fan, Johanna Bendell, Montaser Shaheen, Vijay Patel, Steven McCune, Sandy Liu, Ulka Vaishampayan, Arif Hussain, James J. Hsieh, Ivor Percent, Marc Matrana, Hamid Emamekhoo, Robert Motzer, Chung-Han Lee
Supplementary Figure from Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2715c83537f8cbfd72bcae33f511a58f
https://doi.org/10.1158/1078-0432.22486787
https://doi.org/10.1158/1078-0432.22486787
Autor:
Nizar M. Tannir, Keith Orford, Lalith Akella, Hema Parmar, Zhentao Zhang, Yousef Zakharia, Arash Rezazadeh Kalebasty, Petros G. Nikolinakos, Oscar B. Goodman, Benjamin A. Gartrell, Alice C. Fan, Johanna Bendell, Montaser Shaheen, Vijay Patel, Steven McCune, Sandy Liu, Ulka Vaishampayan, Arif Hussain, James J. Hsieh, Ivor Percent, Marc Matrana, Hamid Emamekhoo, Robert Motzer, Chung-Han Lee
Supplementary Table from Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::327aa368f9769c6d320925d88254c103
https://doi.org/10.1158/1078-0432.22486784.v1
https://doi.org/10.1158/1078-0432.22486784.v1
Autor:
Young Min Cho, Erik W. Anderson, Sara Guevara, Santiago J. Miyara, Aqsa Iqbal, Judith Aronsohn, Ernesto P. Molmenti, James M. Mumford, Barbara Keber, Farideh Zonouzi-Zadeh, Yousoun Ha, Petros G. Nikolinakos, Brent Flickinger
Publikováno v:
Journal of Clinical Rheumatology and Immunology. 22:22-30
T-cell large granular lymphocyte (T-LGL) leukemia is a rare and indolent clonal disorder of LGLs, associated with rheumatoid arthritis and neutropenia. The authors present a case of a 62-year-old male with rheumatoid arthritis (RA) who was diagnosed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bc3573cfeed02755482506c15d5f37f
https://doi.org/10.1142/s2661341722720026
https://doi.org/10.1142/s2661341722720026
Autor:
Chung-Han Lee, Robert Motzer, Hamid Emamekhoo, Marc Matrana, Ivor Percent, James J. Hsieh, Arif Hussain, Ulka Vaishampayan, Sandy Liu, Steven McCune, Vijay Patel, Montaser Shaheen, Johanna Bendell, Alice C. Fan, Benjamin A. Gartrell, Oscar B. Goodman, Petros G. Nikolinakos, Arash Rezazadeh Kalebasty, Yousef Zakharia, Zhentao Zhang, Hema Parmar, Lalith Akella, Keith Orford, Nizar M. Tannir
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 28(15)
Purpose: Glutaminase is a key enzyme, which supports elevated dependency of tumors on glutamine-dependent biosynthesis of metabolic intermediates. Dual targeting of glucose and glutamine metabolism by the mTOR inhibitor everolimus plus the oral gluta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76bbc0ca1ab53acba9eb114883a5090d
https://pubmed.ncbi.nlm.nih.gov/35576438
https://pubmed.ncbi.nlm.nih.gov/35576438
Autor:
Ralph Zinner, Petros G. Nikolinakos, Katherine B. Winfree, Manuel R. Modiano, David R. Spigel, J. Thaddeus Beck, Susan C. Guba, Andrew Koustenis, Helen J. Ross, Jingyi Liu, Ramaswamy Govindan, Durisala Desaiah, Borys Hrinczenko, Joseph Treat, Symantha Melemed, David M. Waterhouse, Waldo I. Ortuzar, Robert W. Weaver, Coleman K. Obasaju
Publikováno v:
Journal of Thoracic Oncology
Introduction PRONOUNCE compared the efficacy and safety of pemetrexed+carboplatin followed by pemetrexed (Pem+Cb) with paclitaxel+carboplatin+bevacizumab followed by bevacizumab (Pac+Cb+Bev) in patients with advanced nonsquamous non–small-cell lung
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce8ed2b38bd7d5e0c64e13f139d6c0e0
Autor:
Richard B Lanman, Stefanie A Mortimer, Oliver A Zill, Dragan Sebisanovic, Rene Lopez, Sibel Blau, Eric A Collisson, Stephen G Divers, Dave S B Hoon, E Scott Kopetz, Jeeyun Lee, Petros G Nikolinakos, Arthur M Baca, Bahram G Kermani, Helmy Eltoukhy, AmirAli Talasaz
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0140712 (2015)
Next-generation sequencing of cell-free circulating solid tumor DNA addresses two challenges in contemporary cancer care. First this method of massively parallel and deep sequencing enables assessment of a comprehensive panel of genomic targets from
Externí odkaz:
https://doaj.org/article/133fc4af39b34633abd205b896147ca3